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A B S T R A C T   
Establishing functional circulation in bioengineered tissue after implantation is vital for the delivery of oxygen 
and nutrients to the cells. Native cartilage is avascular and thrives on diffusion, which in turn depends on 
proximity to circulation. Here, we investigate whether a gridded three-dimensional (3D) bioprinted construct 
would allow ingrowth of blood vessels and thus prove a functional concept for vascularization of bioengineered 
tissue. Twenty 10 × 10 × 3-mm 3Dbioprinted nanocellulose constructs containing human nasal chondrocytes or 
cell-free controls were subcutaneously implanted in 20 nude mice. Over the next 3 months, the mice were 
sequentially imaged with a 7 T small-animal MRI system, and the diffusion and perfusion parameters were 
analyzed. The chondrocytes survived and proliferated, and the shape of the constructs was well preserved. The 
diffusion coefficient was high and well preserved over time. The perfusion and diffusion patterns shown by MRI 
suggested that blood vessels develop over time in the 3D bioprinted constructs; the vessels were confirmed by 
histology and immunohistochemistry. We conclude that 3D bioprinted tissue with a gridded structure allows 
ingrowth of blood vessels and has the potential to be vascularized from the host. This is an essential step to take 
bioengineered tissue from the bench to clinical practice.   
One sentence summary 
In this study, we used functional MRI methods to visualize the 
development of vascularization in 3D bioprinted constructs. 
1. Introduction 
Reconstructing damaged or absent cartilaginous facial structures, 
such as the nose and auricle, is a challenge for the reconstructive sur-
geon, as cartilage has limited ability to heal and regenerate [1]. The gold 
standard is transplantation of autologous cartilage grafts from another 
location (e.g., ribs) after manual sculpturing [2,3]. These procedures are 
tedious and multistaged, and often cause pain, infection, and disfig-
urement [4,5]. Three-dimensional (3D) bioprinting technology offers 
methods to circumvent these problems by using autologous chon-
drocytes mixed with a biomaterial scaffold that can be printed in the 
desired shape, facilitating cell proliferation and tissue restoration and 
potentially simplifying the reconstruction. 
Reconstruction of lost tissue often requires skin, cartilage, or bone 
substitutes that are considerably larger than can be supported by passive 
diffusion. Chondrocytes are dependent on the diffusion of oxygen and 
nutrients from blood vessels within 100–200 μm [6–8]. Therefore, 
construct size is a major limiting factor for sufficient nutrient supply, 
and vascular network formation is crucial [9,10]. Various approaches 
have been explored to overcome these limitations, including altering the 
geometry and porosity of the scaffold [11–18], using biomimetic vessels, 
and incorporating endothelial and smooth muscle cells, as well as 
growth factors needed for the vascular build-up [8,19–24]. To create 
larger viable implants, vessels generated de novo from endothelial cells 
(vasculogenesis) [25] must connect to the systemic circulation [26–32]. 
We hypothesize that angiogenesis—blood vessel formation assisted by 
germination from existing vessels—can be stimulated by using gridded 
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constructs [33]. Many studies have reported signs of internal blood 
circulation in 3D bioprinted constructs [31], as judged from their sur-
vival over time and the absence of necrotic areas, but the vascularization 
of such constructs has not been visualized longitudinally in vivo. 
MRI-based techniques are widely used to assess the perfusion and 
diffusion properties of native tissues [34–38]. Dynamic 
contrast-enhanced MRI (DCE-MRI) can assess tissue perfusion 
non-invasively. After intravenous injection of contrast agent, the MR 
signal increases in proportion to the concentration of the agent reaching 
a voxel (volume pixel). Functional characteristics of the vasculature can 
be derived by studying the voxel signal before, during, and after contrast 
administration. Mathematical tissue models can be used to extract 
quantitative parameters of, for example, vascular features such as 
permeability surface area product and the transfer rates between the 
extra- and intracellular space. Such models have been extensively used 
to predict and assess the therapeutic response of solid tumors [39]. 
However, this approach requires knowledge of the magnetic relaxation 
properties of the studied tissue and the arterial input function. 
A more straightforward approach is to study semiquantitative fea-
tures of the signal behavior. The arrival time (AT)—the time for MR 
signal amplitude to increase above baseline levels—can provide indirect 
information on oxygen and nutrient transport from the vasculature. A 
short AT indicates an adequately functional vasculature. Similarly, the 
initial slope (IS) of the increasing MR signal after contrast has reached 
the tissue reflects the rate at which contrast enters the interstitial space. 
A high IS indicates higher tissue oxygenation, as shown in an animal 
tumor model [40]. 
Nutrient and oxygen transport from the vasculature to cells by 
diffusion is slowed by cellular membranes and macromolecules in the 
extracellular space and by the viscosity of the extracellular fluid. 
Diffusion-weighted MRI (DWI) can be used to measure the restriction on 
molecular diffusion by sensitizing the MR signal to the motion of water 
molecules and by using so-called diffusion gradients and varying their 
effects in repeated DWI acquisitions. The diffusion coefficient can then 
be determined for each voxel by fitting a monoexponential model to the 
DWI signal decay with increased diffusion weighting. MR techniques are 
noninvasive and suitable for the longitudinal assessment of tissues and 
organs. Both DCE and DWI MRI are clinically translatable techniques 
and are therefore suitable for this project. 
The three main bioprinting techniques, all of which build structures 
layer by layer, are extrusion [41–43], laser-assisted [44–46], and inkjet 
printers [21,47,48]. The extrusion bioprinting technique used in this 
study has the advantage of being able to use high-viscosity bioinks with 
high cell densities. Cellular structures and cell viability can be preserved 
by keeping the extrusion pressure and the shear stress as low as possible 
in the nozzle [49,50]. 
The characteristics and geometry of the bioink allow nutrient 
transport and cell migration, which is also important. Hydrogel, mainly 
consisting of water, promotes passive transport of nutrients and oxygen 
because of its viscosity and permeability properties [51]. After printing 
with nanocellulose bioink containing alginate, gelation is initiated with 
calcium chloride crosslinking. Nanocellulose-alginate bioink has the 
desired characteristics for printing complex structures, such as auricles 
[49], is compatible with human cells [52], and has been used to create 
cartilage-like constructs [53]. In previous in vivo studies, we showed 
that chondrocytes survive and proliferate in structure bioprinted from 
nanocellulose-alginate bioink, eventually forming cartilage-like tissue 
[54]. The constructs supported full-thickness skin grafts, making it 
possible to reconstruct composite structures [55]. Several hydrogels 
have been studied to recreate cartilaginous structures, such as collagen 
[30], alginate [56], hyaluronic acid [57], and synthetic hydrogels such 
as polyethylene glycol [58]. In this study, we used nanocellulose pro-
duced by tunicates. This ultra-pure hydrogel (>99% nanocellulose) has 
extraordinary rheological properties and excellent printability [59–61]. 
Nanocellulose has been approved for human applications by the FDA. 
A critical step to take bioengineered tissue into clinical practice is the 
vascularization of the constructed tissues. Previously, we showed that 
3D bioprinted cartilage constructs in vivo become encapsulated by a thin 
layer of host connective tissue containing blood vessels [54,55]. The 
diffusion range is thus dependent on the diameter of the construct. In 
this study, we implanted 3D bioprinted constructs with a gridded 
structure into nude mice and used noninvasive MRI techniques to 




Twenty 8-week-old female BALB/c nude mice were randomly 
assigned to receive implants that contained human nasoseptal chon-
drocytes or were cell-free. Two mice in the cell-free implant group 
developed ulcerations at the site of the tail catheter and were euthanized 
prematurely. However, the implants were retrieved for histologic anal-
ysis, and the MRI data from both mice were used in the overall analyses. 
The study protocol is provided in Table S1. 
2.2. Magnetic resonance imaging 
Fifteen mice were imaged at day 0 (9 cell-containing and 6 cell-free) 
and the images were briefly analyzed for technical quality (e.g., sus-
ceptibility artifacts, such as surgery-related subcutaneous air bubbles). 
Six mice in the cell-free group underwent 2 or 3 sequential MRI exper-
iments (days 0, 30, and/or 90), and 6 carrying chondrocyte-containing 
constructs were imaged at all four time points (days 0, 7, 30, and 90). 
The MRI data of the mice in the cell-containing group are summarized in 
Fig. 1 and Fig. S3. Representative MR images from one mouse in the cell- 
free group are shown in Fig. S4. 
Supplementary video related to this article can be found at 
https://doi.org/10.1016/j.biomaterials.2021.121002 
2.3. Perfusion 
The parametric maps of AT and initial slope IS on day 0 revealed 
longer AT and lower IS in all the printed constructs than in surrounding 
tissues. However, on day 30, five of the six cell-containing constructs 
had hot spots of shorter AT and higher IS at grid hole locations (Fig. 1 
and Movie S1B). AT and IS maps of the sixth construct were more ho-
mogenous and had no hot spots (Fig. S3). The initial variation in MR 
signal intensity in the hot spots after contrast administration was similar 
to that of the aorta, suggesting a close connection to the systemic cir-
culation (Fig. 2). However, during the wash-out phase, the contrast 
agent remained in the implants longer than in the surrounding tissue. On 
day 30, the median signal intensity in the hot spots increased approxi-
mately 130% after contrast injection, whereas the median volume signal 
intensity only increased 110% (data not shown). In the last session (day 
90), the overall perfusion patterns were more homogenous and only one 
of the constructs had vaguely preserved hot spots (Fig. S3D). The cell- 
free constructs had no hot spots at any time (Fig. S4, S8 and S9 Movie 
S2). 
2.4. Diffusion 
The median diffusion coefficient was similar in the cell-containing 
constructs and the cell-free controls (2.56, interquartile range 
2.16–2.97 vs. 2.58, interquartile range 2.24–2.89 μm2/ms, respectively) 
(Fig. 3). The diffusion coefficient remained stable over time (Fig. 4). 
2.5. Morphologic analysis 
Macroscopic analyses of the explanted constructs revealed blood 
vessels sprouting on the surface of the constructs in both groups (Fig. 5 
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and Fig. S6). The cell-containing constructs were well preserved, 
whereas some of the cell-free controls lost their shape and grid structure 
(Fig. S2) and were more fragile and more difficult to handle surgically. 
Microscopic analysis of cell-containing constructs stained with 
hematoxylin-eosin revealed a predominantly homogenous morphology, 
preserved grid holes, and vascular structures containing erythrocytes 
(Fig. 5). In some areas, we observed infiltration of connective tissue in 
the biomaterial beyond the grid holes. Alcian Blue van Gieson (ABvG) 
staining revealed chondrocyte clusters surrounded by glycosaminogly-
cans (GAG) (Fig. 5B), and Safranin-O staining confirmed the production 
of proteoglycans in the extracellular matrix (Fig. 5C). No GAG- or 
proteoglycan-producing cells were found in cell-free constructs 
(Fig. S6). None of the constructs had necrotic areas or histological signs 
of ossification or tumors. The hot spots displayed by perfusion MRI 
corresponded well to the vascularized grid holes (Fig. 5D). 
2.6. Immunohistochemistry 
Analysis for the endothelial cell marker CD31 showed a high density 
of vascular structures, mainly in the grid holes and in the capsule of the 
constructs (Fig. 5E). The immunohistochemical analysis for type 2 
collagen corresponded well to the GAG-positive areas (Fig. 5F and G and 
Fig. S7). Additionally, to evaluate possible endochondral ossification, 
we conducted a supplemental analysis using silver nitrate staining for 
calcification and immunohistochemical analyses for type X collagen 
(Fig. S10–12). No signs of hypertrophic transformation or endochondral 
ossification were detected. 
Bars, 1000 μm (B, C), 500 μm (E, F, G), 100 μm (1, 2, 3) and 50 μm in 
the E magnification. Immunohistochemical analysis of a cell-free 
construct is shown in Fig. S6. Isotype comparison and raw images of F 
in Fig. S7. High-resolution magnifications of F in Fig. S13. The images 
A–G and 1, 2, 3 were cropped and linearly adjusted for contrast and 
exposure time. 
3. Discussion 
In this study, DWI and DCE-MRI were used to analyze the diffusion 
and perfusion properties of gridded 3D bioprinted constructs in nude 
mice in vivo over 90 days. Our findings show that functional blood 
vessels formed inside the 3D bioprinted tissues, providing the necessary 
vascular proximity needed for oxygen and nutrient transport to the 
chondrocytes. Thus, the constructs have the potential to be vascularized 
from the host—an essential step toward the clinical use of bioengineered 
tissue to reconstruct cartilaginous facial structures. 
The gridded geometrical structure of the bioinks may be a key 
feature facilitating the growth of blood vessels and, in combination with 
a permeable biomaterial, such as tunicate nanocellulose/alginate, may 
create an advantageous micromilieu for chondrogenesis. No necrotic 
areas were detected by histology or in vivo DWI, suggesting sufficient 
delivery of oxygen and nutrients. The DWI analysis proved that the 
Fig. 1. DCE MRI signal intensity enhancement and parametric maps. Two chondrocyte-containing constructs and the MRI measurements for days 0, 7, 30, and day 
90. The most significant and visually clear images from either sagittal or coronal planes are presented (A and B) and the constructs are outlined in yellow. Color- 
coded parametric maps of AT and IS reveal several local hot spots (short AT and/or high IS) on day 30 (circled in red). (C–E) The original DCE images used to derive 
the parametric maps are shown for selected time points after contrast injection. The contrast dynamics, with a build-up of local hot spots, are shown for day 0 (D) and 
day 30 (C and E) (Movies S1 and S2). Three minutes after injection of the contrast agent at day 30, the hot spots appear. 9 min after injection, the contrast agent 
gradually dissipates and the hot spot intensity declines. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of 
this article.) 
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diffusion properties of the TNC biomaterial prevailed over time, sug-
gesting that TNC is highly suitable for tissue engineering. Furthermore, 
the shape, dimensions, and solidity of the constructs were better pre-
served in those containing cells; the cell-free constructs were more 
fragile and tore more easily. 
DCE and DWI-MRI are promising tools to assess vascularization in 3D 
bioprinted nanocellulose-based constructs and might be valuable for 
postoperative monitoring of 3D bioprinted implants. The quality and 
resolution of the MR images were, with few exceptions, excellent, and 
could distinguish small variances in perfusion and diffusion between 
different parts of the constructs. Zhou et al. reviewed ultrasound ap-
plications in 3D bioprinting, including visual assessment of vasculari-
zation [62]. Although ultrasound offers cheaper equipment and may be 
more readily available and easier to operate, it lacks the soft tissue 
contrast and resolution offered by MRI, which are major disadvantages. 
Furthermore, computed tomography (CT), including angiography and 
micro-CT, has been used because of its high spatial resolution but also 
lacks the required soft tissue contrast. Additionally, radiation from 
Fig. 2. Hot spot perfusion. (A and B) Comparison of signal intensity curves in hot spots (A) to that of the aorta (B) suggests that vessels in hot spots are closely 
interconnected with the systemic circulation. During the wash-out phase, however, the contrast agent remained longer in the constructs than in the surrounding 
tissue. (C and D) DCE sequence of a representative cell-containing construct at day 30 (C) and the aorta (D). ROIs are delineated in yellow and encompass one hot 
spot (C) and central parts of the aorta (D). AT (C and D middle), and IS (C and D right). Color bars indicate the AT in minutes after injection and the increase in IS 
signal intensity per unit of time. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
Fig. 3. Diffusion. (A and B) T2-weighted, axial images of two representative mice, bearing cell-free (A) and chondrocyte-containing (B) implants (outlined in yellow) 
on day 30. Inserted parametric maps show the corresponding color-coded diffusion coefficient. The median and interquartile range of the diffusion coefficient were 
determined for each implant by manually delineating visible implant on all images, avoiding air/fluid pockets and artifacts. The median diffusion coefficient and 
interquartile range were 2.73 (2.37–3.02) μm2 /ms in the cell-free construct and 2.34 (2.07–2.65) μm2 /ms in the chondrocyte-containing construct. The slight 
misalignment between the diffusion maps and the anatomical images was caused by susceptibility differences between air and tissue, affecting the DWI measure-
ments. The color bar indicates the diffusion coefficient in μm2 /ms. (For interpretation of the references to color in this figure legend, the reader is referred to the Web 
version of this article.) 
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repeated examinations may affect the radiosensitive cells involved in 
vascularization [63]. 
Initially, AT was long, and IS was low in the printed constructs, 
indicating lower perfusion than in surrounding tissues. Over time, 
however, signal intensity hot spots appeared in five of the six cell- 
containing constructs, corresponding perfectly to the grid holes. The 
AT in the hot spots was comparable to that in the aorta; thus, vessels in 
the bioprinted construct were integrated with the systemic circulation of 
the host. The cell-free constructs appeared to be generally more homo-
geneous on the parametric maps of AT and IS at all time points, and no 
hot spots developed. In the cell-containing constructs at day 90, the hot 
spots were indistinguishable, but the overall perfusion had improved 
and in major parts of the constructs was comparable to that in sur-
rounding tissues. 
This observation suggests that by day 90, a neovascular network had 
been established in which a few single supplying vessels in the grid holes 
were less dominant, and the blood flow was more evenly distributed 
over a larger number of smaller vessels that could not be detected as hot 
spots. This interpretation is supported by morphological and immuno-
histochemical evidence that blood vessels were distributed throughout 
the grid holes. The vessels contained erythrocytes, confirming the 
connection to the systemic circulation. The presence of chondrocytes 
created a vascularization pattern displaying hot spots, which did not 
form in the cell-free constructs. The difference in vascularization pat-
terns could reflect the upregulation of angiogenic growth factors (e.g., 
vascular endothelial growth factor) in hypoxic chondrocytes, which 
stimulated vascularization [64]. Furthermore, IS declined continuously 
in the cell-free constructs, whereas cell-containing constructs generally 
displayed a steeper IS throughout the study period. 
The diffusion coefficient was significantly higher in the constructs 
than in native cartilaginous tissue, estimated to be 1.5–2 μm2/ms [65], 
and remained stable, indicating beneficial diffusion properties of the 
bioink. The constructs showed no tendency to disintegrate over 90 days 
in vivo, as shown macroscopically, histologically, or on MR images. The 
preserved, and high, diffusion coefficient may well reflect an important 
microstructural characteristic of the biomaterial—that the preserved 
diffusion facilitates passive transport of nutrients and oxygen, which 
allows cells in the construct to survive, proliferate, and eventually create 
the desired type of tissue. Speculatively, a degrading ink with less 
favorable diffusion properties would offer a less suitable environment 
for the cells and hence offer less opportunity to make 3D bioprinting 
successful. Taken together with the successful vascularization, the 
favorable diffusion qualities further support 3D bioprinted tissue as a 
tentative source of tissue for reconstructive purposes. 
Histologically, both the cell-free and the chondrocyte-containing 
constructs had large quantities of vascular structures containing eryth-
rocytes, which corroborated the hypothesized vessel growth, as did the 
immunohistochemical analysis, which showed endothelial cells lining 
the tube-like structures, mainly in the grid holes (Fig. 5). The chon-
drocytes proliferated, as judged by their even distribution and clustering 
and the production of GAG and collagen type II. Interestingly, chon-
drocytes were found in the biomaterial at the same distances from the 
grid holes throughout the sections, presumably where the oxygen 
pressure was most adequate. Visually, this created a halo-like zone 
around the best perfused areas (i.e., grid holes). 
Proximity to blood circulation and optimal conditions for rapid 
angiogenesis are crucial when creating composite structures, such as the 
external ear. Unlike cartilaginous tissue, skin and adipose tissues cannot 
rely on diffusion. In this study, we used chondrocytes to secrete angio-
genetic factors and grid holes to facilitate the ingrowth of blood vessels. 
The bioink and cartilaginous tissue were not infiltrated by vessels. We 
did not find any hypertrophic chondrocytes or other signs of ossification. 
We have previously shown long-term data for cartilaginous con-
structs in vivo [66]. In that study, no indications of hypertrophic 
transformation or ossification were observed. In native, periarticular 
cartilage, the transformation zone is characterized by progressive hy-
pertrophy, calcification, and subsequent bone formation. However, in 
our studies, the chondrocyte phenotype is preserved and histologically 
displays healthy, proliferating chondrocytes over at least 10 months. 
One instigating factor for bone transformation in the periarticular zones 
is compressive, axial forces. Also, specific transformation factors present 
in, for example, synovial fluid drive the endochondral ossification pro-
cess in a joint. In our studies, no such external factors affect the sub-
cutaneously implanted constructs. Supposedly, this is one explanation 
for why no transformation is detected. 
Cartilage is an avascular, aneural, and alymphatic tissue with limited 
ability to regenerate. However, chondrocytes are very robust and resil-
ient, making them suitable for basic research in tissue engineering. 
Many research groups have developed viable methods to create tissues 
of various kinds but failed to scale up the dimensions due to a lack of 
vascularization. Our objective in the present study was to evaluate a 
clinically viable reconstructive method for bioprinted tissue, focusing 
especially on the crucial vascularization process. Potentially, further 
understanding of angiogenesis can bring us closer to tissue engineered 
constructs with larger dimensions. 
This study was limited by the difficulty of ensuring identical condi-
tions between each experimental time point and between individual 
mice. The main source of error in the diffusion data may be 
susceptibility-related artifacts due to proximity to extracorporeal air, 
resulting in image shearing. Furthermore, postoperative artifacts, such 
as subcutaneous air, may displace pixels in the images, complicating 
their interpretation early after surgery. Moreover, reproducibility- 
related effects due to geometrical misalignment between repeated ex-
periments affect the results of DCE perfusion measurements, which are 
dependent on subjectively drawn regions-of-interest (ROIs). For 
example, perfusion was higher in the capsule surrounding each implant 
than in the implant. Including the capsule in the ROI would inadver-
tently bias the results. An alternative to ROI analysis is to subjectively 
assess the appearance of the DCE parameter maps over time, but this 
approach precludes statistical analysis. Also, the amount of contrast 
Fig. 4. Diffusion coefficient. (A and B) The median diffusion coefficient (D) was 
relatively stable over the study period without obvious trends in the cell- 
containing (A) or the cell-free (B) constructs. The median pooled diffusion 
coefficient (all time points and voxels) was 2.56 (interquartile range 2.16–2.97) 
μm2/ms for the cell-containing constructs and 2.58 (2.24–2.89) μm2/ms for the 
cell-free constructs. The diffusion data are from 29,877 samples (n = number of 
voxels). Lines inside the boxes indicate the median; box edges indicate inter-
quartile range. Whiskers extend to maximum and minimum values; outliers are 
presented as dots outside the whiskers. 
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agent and the injection time in relation to the receiving vessel’s volume 
affects the signal intensity. These uncertainties make it challenging to 
compare mice within a group or in different groups (carrying different 
constructs). More studies are needed to further evaluate the MRI anal-
ysis of artificial tissues to exploit the full potential of this imaging 
technique. 
Autologous 3D bioprinted cartilaginous tissue has significant clinical 
potential in reconstructive surgery. Whether the need is for alar cartilage 
to stabilize a reconstructed nose wing, or even a whole cartilage scaffold 
for an auricle, delivery of oxygen and nutrients to the cells is crucial. Our 
study indicates that grid formation in 3D bioprinted constructs con-
taining chondrocytes promotes angiogenesis in vivo and that this pro-
cess can be further understood by using noninvasive MRI methods. 
In summary, our findings provide important information on vascu-
larization of 3D bioprinted tissue—a critical step in the translation of 
bioengineered tissue into clinical practice. The favorable diffusion 
properties of nanocellulose/alginate bioink and the ingrowth of blood 
vessels from the host into the gridded structure are fundamentals for 
increasing the size and biological complexity of 3D bioprinted constructs 
as a source of clinically relevant tissues for reconstructive purposes. 
4. Materials and methods 
4.1. Study design 
Twenty 8-week-old female BALB/c nude mice (Scanbur) were 
randomly assigned to two groups, one implanted with chondrocyte- 
containing constructs (n = 10) and one with cell-free constructs (n =
10), and studied for 90 days. The number of mice was based upon the 
maximum number of MRI sessions that were logistically feasible. In the 
manuscript and supplementary data, all 20 mice are accounted for, and 
images and data from all constructs are presented. The study was not 
blinded. The MR images were briefly analyzed during each scanning 
session, and constructs were selected for further scanning based on 
technical quality. The ARRIVE Guidelines Checklist [67] was used to 
report and describe our methods and results. 
4.2. Cell source and cell expansion 
Human nasoseptal cartilage biopsies were obtained from male do-
nors [age range: 24–40 years; average: 34 ± 5.97 (n = 6)] during routine 
Fig. 5. Cell-containing constructs. (A) 
Macroscopic appearance of a representative 
cell-containing construct. A magnified image 
shows small capsular vessels growing into 
the grid holes. (B and C) Histological core 
sections were stained with ABvG and 
Safranin-O. (2) Magnifications show chon-
drocytes surrounded by GAGs (cloudy blue) 
in the extracellular matrix. (3) Safranin-O 
staining reveals proteoglycans (cloudy or-
ange) in the extracellular matrix surround-
ing the chondrocytes, corresponding well to 
the GAG-positive areas. (1) Magnifications 
of a grid hole containing vessels and eryth-
rocytes; staining with hematoxylin-eosin. 
(D) Color-coded parametric maps of AT 
and IS reveal areas of high contrast 
throughput (i.e., hot spots; encircled in red), 
corresponding well to the location of the 
vascularized grid holes. (E) Immunohisto-
chemical analyses with anti-CD31 antibody 
show dense vascular structures lined with 
endothelial cells (arrows) inside a grid hole. 
(F) Immunohistochemical analysis of type 2 
collagen show positive areas in the extra-
cellular matrix surrounding the chondrocyte 
clusters. See Fig. S13 for details in magnifi-
cation. (G) Outtake from (B) shows the 
ABvG stained surroundings of one grid hole 
where the GAG-positive areas are corre-
sponding well to the type 2 collagen-positive 
areas in (F). (For interpretation of the ref-
erences to color in this figure legend, the 
reader is referred to the Web version of this 
article.)   
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surgery (i.e., septoplasties or septorhinoplasties) at the Department of 
Otorhinolaryngology, Head and Neck Surgery, Charité-Medical Uni-
versity (Berlin, Germany). All cartilage samples were first rinsed in 
sterile 0.1 M phosphate-buffered saline (PBS) and subsequently in 
standard culture medium [Dulbecco’s modified Eagle medium/F-12 
(DMEM; 1:1; Life Technologies, Waltham, MA, USA) supplemented 
with 10% fetal bovine serum (FBS; HyClone; GE Healthcare, South 
Logan, UT, USA) and 1% penicillin/streptomycin (P/S; Biochrom, Hol-
liston, MA, USA)] under sterile conditions. Adherent non-cartilaginous 
tissues, including the perichondrium and epithelium, were removed. 
To isolate human primary nasal chondrocytes (hNCs), cartilage 
samples were sliced into 1 mm × 1 mm pieces, and after discarding the 
medium, transferred to pronase (Serva, Heidelberg, Germany) digestion 
solution [10 mL; 20 mg/mL (2%) pronase in DMEM supplemented with 
1% P/S without FBS]. For the first round of pronase digestion, samples 
were incubated at 37 ◦C and 5% CO2 for 45 min–60 min under contin-
uous agitation, after which the pronase solution was discarded, and pre- 
digested cartilage samples were washed twice with sterile 1 × PBS. For 
the final digestion, cartilage samples were transferred to collagenase 
(Gibco; Life Technologies, Carlsbad, CA, USA) digestion solution [1 mg/ 
mL (0.1%) collagenase in DMEM complemented with 0.5% FBS and 1% 
P/S] and incubated for 16 h–18 h at 37 ◦C and 5% CO2 with continuous 
shaking. After centrifugation, total cell number and viability were 
determined using the Trypan blue exclusion method (Table S2). Sub-
sequently, hNCs were seeded for amplification at an initial density of 5 
× 103 cells/cm2 and cultured in a standard culture medium. Upon 
reaching 80%–90% confluence, cells were detached, counted (Cell 
Counter; Thermo Fisher Scientific, Waltham, MA, USA), and cry-
opreserved to ensure equal treatment of all hNCs harvested from 
different patients. Cryopreserved hNCs were thawed and expanded once 
in monolayer culture to obtain a sufficient number of cells. Upon 
reaching 80%–90% confluence, cells were detached, counted, and 
resuspended in a standard culture medium. All experiments were con-
ducted using hNCs at passage two. 
4.3. Preparation of bioinks and 3D bioprinting 
The hNCs were gently mixed with bioink consisting of an 80:20 
mixture of tunicate nanocellulose (Ocean TuniCell, AS, Blomsterdalen, 
Norway) and alginate (SLG100; NovaMatrix, Sandvika, Norway). The 
hNC to ink ratio was 1:10, and the initial cell density was 10 × 106 cells/ 
ml of bioink. Cell-free samples were also prepared. The bioink was 3D 
bioprinted (Inkredible+, CELLINK) as gridded square constructs (10 ×
10 × 3 mm) with a 25% rectilinear infill. An 18G conical nozzle was 
used, and the printing pressure was 11–13 kPa. The constructs were 
crosslinked with 0.5 mM CaCl2 for 5 min, washed in culture medium 
(Dulbecco’s modified Eagle medium/F-12 (DMEM; 1:1; Life Technolo-
gies, Waltham, MA, USA), and implanted within 1 h after printing. 
4.4. Animal model 
The mice were anesthetized with isoflurane (Isoflurane Baxter, 
Baxter International), and the 3D-bioprinted constructs were implanted 
subcutaneously in the neck/back region. No antibiotics were used. Each 
mouse was identified with an earmark. 
4.5. MRI 
During MRI experiments, anesthesia was maintained with 2–3% 
isoflurane (Isoba vet., Schering-Plough Animal HealthK). Body temper-
ature was maintained with a heating pad on the animal holder, and 
respiration was monitored with a pressure-sensitive pad (SA In-
struments). Gadolinium-based contrast agent solution (0.1 M Gd-DTPA, 
Dotarem, Gothia Medical; 0.3 mmol/kg body weight) was administered 
with a peripheral venous catheter placed in a tail vein and connected to a 
1-mL syringe by an infusion line extending out of the magnet bore. 
MRI was done with a preclinical, horizontal bore 7 T MR system 
(Bruker BioSpin 70/20AS AVANCE 1 using ParaVision 5.1) equipped 
with a maximum 400 mT/m gradient system and a 30-mm transmit/ 
receive volume coil (RAPID Biomedical). Global first- and second-order 
shimming was used to improve field homogeneity. Conventional two- 
dimensional (2D) T2-weighted images of the implant and surrounding 
anatomy were acquired in axial and coronal views with the rapid 
acquisition with relaxation enhancement (RARE) sequence: repetition 
time (TR) 3000 ms, echo time (TE) = 24 ms, turbo factor = 4, number of 
signal averages (NSA) = 61502 μm2 in-plane resolution, and slice 
thickness of 500 μm (axial) or 400 μm (coronal). DCE images were ac-
quired with the 2D, retrospectively gated, intra-gate, fast low-angle shot 
sequence: TR = 13 ms, TE = 1.1 ms, NSA = 11,500 repetitions over ~32 
min for the reconstruction of 32 time frames, 3002 μm2 in-plane reso-
lution, and 1000-μm slice thickness. The navigator signal was derived 
from a 45-mm-thick saturation slice including the image slices in par-
allel orientation. At the start of the acquisition of the sixth frame (5 min 
after the scan was started), the contrast agent was injected over 10 s. 
DWI was done with a 2D single-shot, spin-echo echo-planar imaging 
sequence: TR = 3500 ms, TE = 25 ms, NSA = 14, 5 acquisitions without 
diffusion gradients (b = 0 s/mm2) and 12 acquisitions at b-values of 50, 
200, 400, and 900 s/mm2, in 3 orthogonal diffusion directions. Gradient 
duration was 4 ms and separation was 9 ms. EPI image readout: 2502 
μm2 in-plane resolution, 700-μm slice thickness. 
Each MRI session took about 75 min per mouse, after which the mice 
were returned to their cages and monitored until fully alert. After the 
fourth and last scanning, the mice were euthanized by cervical dislo-
cation while still under anesthesia. The MRI data were post-processed 
with MATLAB (R2019b, The MathWorks) with standard and in-house 
developed functions and scripts. 
DCE MR signal intensity enhancement in the implant after contrast 
injection was analyzed voxel-wise as follows. The baseline voxel in-
tensity was calculated as the mean signal intensity of the first five 
frames. The AT was defined as the time required from injection to the 
point at which signal intensity in a voxel was twice the voxel noise level 
above the baseline value. Voxel noise was defined as the standard de-
viation of the voxel signal values of the five frames before contrast in-
jection. Functional maps were constructed by superimposing color- 
coded AT values on the baseline image (Fig. S5). The detected MRI 
signal intensity is relative to baseline, which potentially differs from 
session to session. Each baseline was therefore calibrated by comparing 
the signal intensity of the construct with that of native muscle tissue. The 
DCE signal intensity was also quantified by using region-of-interest 
(ROI) maps from the MRI data, creating graphs that enabled further 
interpretations and comparisons between the different constructs. 
Diffusion coefficient maps were calculated for each voxel by 
segmented bi-exponential model fitting, which renders the diffusion 
coefficient minimally affected by perfusion effects by fitting it only to b- 
values of 200, 400, and 900 s/mm2 [40]. The median diffusion coeffi-
cient of each implant was calculated from all voxels within the implant 
by manually delineating it on the b = 0 s/mm2 (B0) images. Slices 
covering the edges of the implant were excluded to avoid partial volume 
effects. 
4.6. Morphology 
For in vitro controls on day 0, the printed constructs were directly 
fixed in calcium-saturated (4%) paraformaldehyde and stored at 4 ◦C. 
All constructs were paraffinized, sectioned (5 μm thick) horizontally, 
and mounted on glass slides (Fig. S1). On day 90, the constructs were 
retrieved, macroscopically examined, marked for orientation with tissue 
dye (Thermo Fisher Scientific), fixed in calcium-saturated 4% para-
formaldehyde, and stored at 4 ◦C until paraffinization and sectioning. 
Deparaffinized sections were stained with hematoxylin-eosin, ABvG, 
and Safranin-O. The sections were scanned with a Nikon Eclipse 90i epi- 
fluorescence microscope equipped with a Nikon DS-Fi2 color head 
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camera and a NIS-Elements imaging software suite (vD4.10.02; Nikon 
Instruments). The images were imported into PhotoShop 2020 (Adobe 
Systems) and cropped, white-balanced, and linearly adjusted for 
contrast and exposure. 
4.7. Immunohistochemistry 
Endothelial cells were detected with a human anti-CD31 antibody 
(clone EP3095, product no. ab134168, Abcam; 1:200). Human liver 
tissue served as a positive control. A rabbit IgG isotype control (clone 
EPR25A, product no. ab172730, Abcam) and secondary antibodies 
alone served as negative controls to differentiate background signal 
from specific antibody staining. CD31-positive cells were identified with 
the Vectastain Elite ABC kit, a biotinylated secondary antibody 
(PK6101; BioNordika), and ImmPACT DAB (H-4000; BioNordika). 
To assess collagen production in the extracellular matrix, the sections 
were incubated first with a monoclonal mouse antihuman type 2 
collagen antibody IgG (Clone II-4C11, catalog no. 63171, MP Bio-
medicals; 1:300) and then with goat anti-mouse IgG conjugated with 
AlexaFluor 546 (A11030, Invitrogen; 1:300), and the mounting solution 
was applied (ProLong Gold antifade mountant with DAPI; Invitrogen). 
Cartilage pellets from horse served as a positive control. A monoclonal 
mouse IgG antibody (mouse IgG1 K isotype control purified, catalog no. 
14-4714-82, eBioscience, Thermo Fisher Scientific; 1:75) served as 
control. 
Ethical approval 
Cartilage harvesting was approved by the Ethics Committee at 
Charité Universitätsmedizin in Berlin (No.: EA1/169_12), and all pa-
tients gave informed consent. The study was approved by the Ethics 
Committee for animal experiments at Sahlgrenska University Hospital 
(Dnr 119–2015 and 36–2016). Ethical approval for the positive controls 
in the immunohistological analyses was issued by the Ethics Committee 
at the University of Gothenburg (Gothenburg, Sweden, Dnr S040-01). 
All animal experiments were done following institutional, national, 
and European guidelines and regulations at the core facility for experi-
mental biomedicine at the University of Gothenburg. 
4.8. Statistics 
Histograms of the diffusion coefficients showed normal distribution, 
so a normality test was unnecessary. The medians and interquartile 
ranges were calculated and graphed with SPSS (v22.0; IBM SPSS) and 
Microsoft Excel (v16.28). 
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